These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 35497797)

  • 1. Genetic Variants of
    Hung RKY; Binns-Roemer E; Booth JW; Hilton R; Harber M; Santana-Suarez B; Campbell L; Fox J; Ustianowski A; Cosgrove C; Burns JE; Clarke A; Price DA; Chadwick D; Onyango D; Hamzah L; Bramham K; Sabin CA; Winkler CA; Post FA;
    Kidney Int Rep; 2022 Apr; 7(4):786-796. PubMed ID: 35497797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synbiotics, prebiotics and probiotics for people with chronic kidney disease.
    Cooper TE; Khalid R; Chan S; Craig JC; Hawley CM; Howell M; Johnson DW; Jaure A; Teixeira-Pinto A; Wong G
    Cochrane Database Syst Rev; 2023 Oct; 10(10):CD013631. PubMed ID: 37870148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Dapagliflozin on Cardiovascular Outcomes According to Baseline Kidney Function and Albuminuria Status in Patients With Type 2 Diabetes: A Prespecified Secondary Analysis of a Randomized Clinical Trial.
    Zelniker TA; Raz I; Mosenzon O; Dwyer JP; Heerspink HHJL; Cahn A; Goodrich EL; Im K; Bhatt DL; Leiter LA; McGuire DK; Wilding JPH; Gause-Nilsson I; Langkilde AM; Sabatine MS; Wiviott SD
    JAMA Cardiol; 2021 Jul; 6(7):801-810. PubMed ID: 33851953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.
    Tunnicliffe DJ; Palmer SC; Cashmore BA; Saglimbene VM; Krishnasamy R; Lambert K; Johnson DW; Craig JC; Strippoli GF
    Cochrane Database Syst Rev; 2023 Nov; 11(11):CD007784. PubMed ID: 38018702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the prevalence and associated factors of chronic kidney disease diagnosed by serum creatinine or cystatin C among young people living with HIV in Uganda.
    Nasuuna EM; Tomlinson LA; Kalyesubula R; Dziva Chikwari C; Castelnuovo B; Manabe YC; Nakanjako D; Weiss HA
    BMC Nephrol; 2024 Nov; 25(1):422. PubMed ID: 39587464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defining the optimum strategy for identifying adults and children with coeliac disease: systematic review and economic modelling.
    Elwenspoek MM; Thom H; Sheppard AL; Keeney E; O'Donnell R; Jackson J; Roadevin C; Dawson S; Lane D; Stubbs J; Everitt H; Watson JC; Hay AD; Gillett P; Robins G; Jones HE; Mallett S; Whiting PF
    Health Technol Assess; 2022 Oct; 26(44):1-310. PubMed ID: 36321689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implementation and outcomes of dolutegravir-based first-line antiretroviral therapy for people with HIV in South Africa: a retrospective cohort study.
    Dorward J; Sookrajh Y; Khubone T; van der Molen J; Govender R; Phakathi S; Lewis L; Bottomley C; Maraj M; Lessells RJ; Naidoo K; Butler CC; Van Heerden R; Garrett N
    Lancet HIV; 2023 May; 10(5):e284-e294. PubMed ID: 37001536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Education programmes for people with chronic kidney disease and diabetes.
    Cashmore BA; Cooper TE; Evangelidis NM; Green SC; Lopez-Vargas P; Tunnicliffe DJ
    Cochrane Database Syst Rev; 2024 Aug; 8(8):CD007374. PubMed ID: 39171639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The natural history of renal disease in Australian Aborigines. Part 2. Albuminuria predicts natural death and renal failure.
    Hoy WE; Wang Z; VanBuynder P; Baker PR; McDonald SM; Mathews JD
    Kidney Int; 2001 Jul; 60(1):249-56. PubMed ID: 11422758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Albuminuria-based stratification of end-stage kidney disease progression and mortality with sodium-glucose cotransporter 2 inhibitors (SGLT2i): A retrospective cohort study in type 2 diabetes and chronic kidney disease.
    Chang TJ; Lee YC; Wu LC; Chang CH
    Pharmacotherapy; 2024 Nov; 44(11):828-840. PubMed ID: 39382257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antioxidants for adults with chronic kidney disease.
    Colombijn JM; Hooft L; Jun M; Webster AC; Bots ML; Verhaar MC; Vernooij RW
    Cochrane Database Syst Rev; 2023 Nov; 11(11):CD008176. PubMed ID: 37916745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences.
    Pillay J; Gaudet LA; Saba S; Vandermeer B; Ashiq AR; Wingert A; Hartling L
    Syst Rev; 2024 Nov; 13(1):289. PubMed ID: 39593159
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Chaudhary NS; Moore JX; Zakai NA; Judd SE; Naik RP; Limou S; Cushman M; Lange LA; Wang HE; Winkler CA; Irvin MR; Kopp JB; Gutiérrez OM
    Clin J Am Soc Nephrol; 2019 Dec; 14(12):1733-1740. PubMed ID: 31704668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stemming the tide: reducing cardiovascular disease and renal failure in Australian Aborigines.
    Hoy W; Kelly A; Jacups S; McKendry K; Baker P; MacDonald S; Wang Z; Punguatji N; Kerinauia J; Tipiloura E; Tipiloura E; Harrison C
    Aust N Z J Med; 1999 Jun; 29(3):480-3. PubMed ID: 10868523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Galantamine for dementia due to Alzheimer's disease and mild cognitive impairment.
    Lim AWY; Schneider L; Loy C
    Cochrane Database Syst Rev; 2024 Nov; 11(11):CD001747. PubMed ID: 39498781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV care cascade and associated factors among men who have sex with men, transgender women, and genderqueer individuals in Zimbabwe: findings from a biobehavioural survey using respondent-driven sampling.
    Harris TG; Wu Y; Parmley LE; Musuka G; Mapingure MP; Chingombe I; Mugurungi O; Hakim A; Gozhora P; Miller SS; Lamb MR; Samba C; Rogers JH
    Lancet HIV; 2022 Mar; 9(3):e182-e201. PubMed ID: 35150606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results of an Aboriginal community-based renal disease management program incorporating point of care testing for urine albumin:creatinine ratio.
    Shephard MD; Allen GG; Paizis K; Barbara JA; Batterham M; Vanajek A
    Rural Remote Health; 2006; 6(4):591. PubMed ID: 17022724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An arterial spin labeling-based radiomics signature and machine learning for the prediction and detection of various stages of kidney damage due to diabetes.
    Ma F; Shao X; Zhang Y; Li J; Li Q; Sun H; Wang T; Liu H; Zhao F; Chen L; Chen J; Zhou S; Ji Q; Yu P
    Front Endocrinol (Lausanne); 2024; 15():1333881. PubMed ID: 39624821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Baseline liver function tests and full blood count indices and their association with progression of chronic kidney disease and renal outcomes in Aboriginal and Torres Strait Islander people: the eGFR follow- up study.
    Majoni SW; Barzi F; Hoy W; MacIsaac RJ; Cass A; Maple-Brown L; Hughes JT
    BMC Nephrol; 2020 Dec; 21(1):523. PubMed ID: 33261565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peritoneal dialysis versus haemodialysis for people commencing dialysis.
    Ethier I; Hayat A; Pei J; Hawley CM; Johnson DW; Francis RS; Wong G; Craig JC; Viecelli AK; Htay H; Ng S; Leibowitz S; Cho Y
    Cochrane Database Syst Rev; 2024 Jun; 6(6):CD013800. PubMed ID: 38899545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.